Back to feed

Wanda Health secures £1m to revolutionise remote patient monitoring and expand US operations

🔎
Wanda Health
🧑
Tom Smith
🤝
No items found.
EMV Capital
💰
£1m
🌎
Bristol, United Kingdom
Dec 9, 2024

Wanda Health, the intelligent platform for Remote Patient Monitoring and Virtual Care, has successfully closed a fundraising of £1 million. The funding was led and syndicated by EMV Capital.

The proceeds from the fundraising will provide Wanda Health with the capital to execute its growth strategy, which includes:

  • Enhancing its AI capabilities by developing disease-specific AI algorithms for readmission risk.
  • Expanding its market presence in US markets by targeting 'Fee for Service' and 'Value Based Care' models.
  • Developing white label solutions for its growing partner network in order to unlock new revenue streams across market segments.
  • Advancing regulatory pathways toward FDA clearance for the first outpatient-based adjunctive predictive cardiovascular risk indicator.

Wanda Health recently announced a high-profile partnership with COPD Foundation providing it with access to world-leading clinical experts, clinical guideline content, as well as joint marketing and advertising opportunities. This collaboration enhances Wanda Health's ability to refine its disease monitoring platform, particularly for conditions like COPD, which affects over 400 million people globally.

Wanda Health, a spinout from UCLA, is a leading remote patient monitoring and virtual care platform operating in the UK and US. Delivered as a Software-as-a-Service (SaaS) solution, it is cloud-hosted with proprietary machine learning (ML) and artificial intelligence (AI) capabilities. Wanda Health empowers healthcare providers and payers by enabling early detection of health exacerbations across acute, chronic, and specialty disease spaces, improving patient outcomes and reducing costs.

Wanda Health operates in a high-growth sector, with RPM projected to grow to $175 billion by 2027, Remote Therapeutic Management estimated to reach $17 billion by 2030, and Chronic Care Management predicted to reach $32 billion by 2033. With a robust pipeline of growth opportunities, Wanda Health is well-positioned to lead the way in RPM and Virtual Care.

We are delighted to see Wanda Health successfully close this fundraising. This is a pivotal moment for Wanda Health as it continues to grow its leadership position in the rapidly expanding RPM market, building on its trans-Atlantic presence in the UK and US. EMV Capital is proud to have contributed strategic and investment support through our Venture Building programme. We look forward to seeing Wanda Health's impact grow as it scales its operations in the US and beyond.
Dr Ilian Iliev, CEO of EMV Capital